Literature DB >> 3743613

The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.

R A Greenbaum, S Wan, T R Evans.   

Abstract

Nicardipine is a new slow channel calcium blocker. It has been shown to be effective in the treatment of hypertension and angina pectoris. Nine patients with mild to moderate left ventricular failure were given intravenous infusions of nicardipine and the haemodynamic effects measured. In patients receiving 20 mg of nicardipine, mean cardiac index rose to a peak 1.81 X min-1 X m-2 (64%) above the preinfusion level, stroke volume index rose by 12 ml X m-2 (35%) and heart rate rose by 16 beats X min-1 (20%). There was a significant fall in systemic vascular resistance of 50% manifested by a reduction of 22 mm Hg in systolic blood pressure (18%) and 18 mm Hg in diastolic blood pressure (22%). Pulmonary vascular resistance fell by 45%. Mean pulmonary artery pressure and capillary wedge pressure did not change significantly. This study suggests that concomitant mild to moderate left ventricular failure is not a contra-indication to nicardipine therapy in patients with angina.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743613     DOI: 10.1007/bf00607948

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

Review 1.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.

Authors:  M F Rousseau; M F Vincent; P Cheron; G van den Berghe; A A Charlier; H Pouleur
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

3.  Calcium-channel blockers: pharmacologic considerations.

Authors:  E Braunwald
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

4.  Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine.

Authors:  M F Rousseau; C Veriter; J M Detry; L Brasseur; H Pouleur
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

5.  The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.

Authors:  R I Jones; R S Hornung; T Sonecha; E B Raftery
Journal:  J Hypertens       Date:  1983-06       Impact factor: 4.844

6.  Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.

Authors:  B Silke; S P Verma; M Hussain; N C Jackson; M Hafizullah; G Reynolds; S H Taylor
Journal:  Herz       Date:  1985-04       Impact factor: 1.443

7.  Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

Authors:  J Bayliss; M S Norell; R Canepa-Anson; C Reid; P Poole-Wilson; G Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

8.  Physiologic basis of vasodilator therapy for heart failure.

Authors:  J N Cohn
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

9.  Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.

Authors:  R P Hof
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

10.  Hemodynamic effects of nifedipine in congestive heart failure.

Authors:  S Matsumoto; T Ito; T Sada; M Takahashi; K M Su; A Ueda; F Okabe; M Sato; I Sekine; Y Ito
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

View more
  3 in total

Review 1.  Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.

Authors:  Monique P Curran; Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.

Authors:  V A Naukkarinen; K Karppinen; S Sarna
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.